TIFFANY KAUL
LA JOLLA, CA NPI 1669050514
Browse related groups: CA SOBI, INC All categories
General Payments — all program years on this page
$1,154.56
- Category: General Payments
- Program years: PY2023–2024
- Record count: 42
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,049.35 across 37 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $869.41 | 35 |
| Education | $179.94 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| SOBI, INC | $131.42 | 5 |
| AVEO Pharmaceuticals, Inc. | $127.87 | 2 |
| Janssen Biotech, Inc. | $95.23 | 2 |
| GlaxoSmithKline, LLC. | $88.74 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $87.01 | 3 |
| EISAI INC. | $70.08 | 3 |
| Genentech USA, Inc. | $48.17 | 2 |
| SERVIER PHARMACEUTICALS LLC | $39.02 | 2 |
| Dendreon Pharmaceuticals LLC | $35.00 | 1 |
| Celgene Corporation | $33.18 | 1 |
| Acerta Pharma LLC | $30.66 | 1 |
| Blueprint Medicines Corporation | $29.71 | 1 |
| Exelixis Inc. | $29.21 | 1 |
| TAIHO ONCOLOGY, INC. | $28.83 | 1 |
| Daiichi Sankyo Inc. | $25.30 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $25.24 | 1 |
| Agios Pharmaceuticals, Inc. | $24.04 | 1 |
| Incyte Corporation | $22.81 | 1 |
| Alexion Pharmaceuticals, Inc. | $20.61 | 1 |
| Tempus AI, Inc | $19.69 | 1 |
| Lilly USA, LLC | $18.92 | 1 |
| TerSera Therapeutics LLC | $18.61 | 1 |
By program year
Records — PY2024 (37)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.